IMJ January 2026 #FreeAccess Editor's Choice (Review): Thiazide-induced hyponatraemia bit.ly/3Z3vk4R @theracp.bsky.social

IMJ January 2026 #FreeAccess Editorial: I visited 145 Macquarie Street bit.ly/3Z3uYet @theracp.bsky.social

IMJ January 2026 #FreeAccess Review: Management of HIV in cardiovascular disease bit.ly/3Z5qwfe @theracp.bsky.social @ianjohnwoolley.bsky.social

IMJ January 2026 #FreeAccess Original Article: Iron deficiency and anaemia in inflammatory bowel disease bit.ly/45DdAB1 @theracp.bsky.social

IMJ January 2026 #FreeAccess Original Article: Cholesterol treatment in type 1 diabetes bit.ly/4jMp8HS @theracp.bsky.social

IMJ January 2026 #OpenAccess Brief Communication: Tertiary hospital-based gender affirming care bit.ly/4jtRiHE @theracp.bsky.social

IMJ January 2026 #FreeAccess Brief Communication: Hepatic steatosis incidentally detected on lung cancer screening bit.ly/3Z2qGUD @theracp.bsky.social

IMJ February 2026 #FreeAccess Editor's Choice (Review): Midodrine in heart failure bit.ly/4aH5p9K @theracp.bsky.social

IMJ February 2026 #FreeAccess Editorial: Surveillance for poliovirus is just as important as ever bit.ly/4r8t3C1 @theracp.bsky.social @ianjohnwoolley.bsky.social

IMJ February 2026 #FreeAccess Clinical Perspectives: Giant cell arteritis: recent therapeutic advances bit.ly/3Ndhn1B @theracp.bsky.social

IMJ February 2026 #FreeAccess Original Article: Voluntary assisted dying and organ donation bit.ly/4rfPllq @theracp.bsky.social

IMJ February 2026 #FreeAccess Brief Communication: Prolonged waiting times for respiratory and sleep care bit.ly/4rIKBV3 @theracp.bsky.social

IMJ February (Vol 56, Iss 2) is now online bit.ly/4kqgD5L @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ January (Vol 56, Iss 1) is now online bit.ly/45NHpim @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ December 2025 #OpenAccess Clinical Perspective: HIV: is it now a thing of the past? bit.ly/3KQ2AZX @theracp.bsky.social

IMJ December (Vol 55, Iss 12) is now online bit.ly/4pWJiRu @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ November (Vol 55, Iss 11) is now online bit.ly/47HoPbI @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ September 2025 #OpenAccess Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified? bit.ly/3K3qDDO @theracp.bsky.social

IMJ September 2025 #FreeAccess Review: Replacement therapy in congenital adrenal hyperplasia bit.ly/3HF9KPi @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: In-hospital cardiac arrest bit.ly/4p5P8QZ @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: Is incidence and burden of cancer increasing among young individuals? bit.ly/4p88bdh @theracp.bsky.social

IMJ September 2025 #OpenAccess Original Article: Automatic screening for viral hepatitis in an Emergency Department bit.ly/46h53EB @theracp.bsky.social

IMJ September 2025 #FreeAccess Original Article: Lung transplantation for interstitial lung diseases bit.ly/3JELX2B @theracp.bsky.social

IMJ October 2025 #OpenAccess Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it bit.ly/42uVLmg @theracp.bsky.social

IMJ October 2025 #FreeAccess Editorial: A, B, C or D? Goals of Care: a need for a national structural framework. bit.ly/46JpvOI @theracp.bsky.social

A bumper issue of @the-imj.bsky.social Congratulations.

IMJ September (Volume 55, Issue 9) is now online bit.ly/45ZaKpj @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ August 2025 #FreeAccess Editor's Choice (Original Article): Glomerular disease registry and Biobank bit.ly/3ULSydE @theracp.bsky.social @marrow.bsky.social @sunilbadve.bsky.social

IMJ August 2025 #OpenAccess Original Article: Hyperuricaemia in Type 1 Gaucher disease bit.ly/3Hl6zMi @theracp.bsky.social @marrow.bsky.social

IMJ August (Vol 55, Iss 8) is now online bit.ly/3J5Ndvm @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ July 2025 #OpenAccess Editor's choice (review): Generative artificial intelligence in healthcare bit.ly/4loWVXS @theracp.bsky.social GenAI in clinical healthcare could be transformative. However, numerous challenges exist including technological, regulatory, workforce adaption, and trust.

IMJ July 2025 #FreeAccess Editorial: Are Australians Living with Dementia Ready for New Therapies? bit.ly/4eEYE8M @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Alzheimer disease: rollout of amyloid-targeting therapies bit.ly/3Il89Oq @theracp.bsky.social

IMJ July 2025 #FreeAccess Clinical Perspective: Management of pulmonary fibrosis bit.ly/3IkW7EO @theracp.bsky.social New research is expanding pulmonary fibrosis treatment beyond IPF to other fibrotic ILDs, integrating targeted drugs and immunomodulation.

IMJ July 2025 #OpenAccess Original article: ‘No man's land’ – transition to adulthood for young adults with complex health needs bit.ly/4nITRaC @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Terminal heart failure care for women bit.ly/44UDDDH @theracp.bsky.social

IMJ July 2025 #OpenAccess Original Article: Allogeneic haemopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia bit.ly/3Iltfw0 @theracp.bsky.social

IMJ July (Vol 55, Iss 7) is now online bit.ly/3U2KC7s @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

Want to learn about the prevention of thrombosis in patients with PNH?🩸 Make sure to watch our recent interview from #IPIG2025 with @marrow.bsky.social‬ of @petermaccc.bsky.social‬ in which he discusses this: 🎥 buff.ly/i8Ry0Zr #RareDisease #Hematology #Thrombosis #BloodSky #MedSky

IMJ June 2025 #FreeAccess Editorial: "Two decades at the helm: it only seems like a few weeks". Former Editor-in-Chief (now Emeritus Editor) Jeff Szer looks back at his many years on the IMJ. bit.ly/3FNAg86 @theracp.bsky.social @marrow.bsky.social

IMJ May 2025 #OpenAccess Editor's choice (clinical perspective): Chimeric antigen-T cells and bispecific antibodies bit.ly/3Z3Hrj1 @theracp.bsky.social @marrow.bsky.social

IMJ May (Vol 55, Iss 5) is now online bit.ly/4iVn7XW @theracp.bsky.social @marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

IMJ April 2025 #FreeAccess Review: Telehealth research trends in Australia bit.ly/3R9ZyPM @marrow.bsky.social @theracp.bsky.social

IMJ April 2025 #FreeAccess Editorial: Climate stewardship in healthcare. Health professionals need to walk the talk in climate change behaviour modelling. bit.ly/3G0TuXB @marrow.bsky.social @theracp.bsky.social

IMJ Apr 2025 #FreeAccess Editor's choice (original article): Cerebral microbleeds in an Australian Memory clinic bit.ly/4cxFzo8 @marrow.bsky.social @theracp.bsky.social

IMJ April (Vol 55, Issue 4) is now online bit.ly/3R38tCq @marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social

This was a fun episode. Thanks Jenny.

IMJ March 2025 #FreeAccess Brief communication: Non-invasive ventilation in cystic fibrosis bit.ly/3FgHSPF @marrow.bsky.social @theracp.bsky.social

IMJ March 2025 #OpenAccess Brief communication: Bronchiectasis exacerbations among adult Indigenous Australians in the Top End bit.ly/4iHxgaX @marrow.bsky.social @theracp.bsky.social @flindersuniversity.bsky.social @charlesdarwinuni.bsky.socia

IMJ March 2025 #OpenAccess Original article: Return to work in lung transplant recipient bit.ly/43BhQRh @marrow.bsky.social @theracp.bsky.social